Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL

Enrollment

271

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

May 31, 2006

Conditions

Psoriasis

Interventions

DRUG

adalimumab

40 mg every other week following an 80 mg dose

DRUG

MTX

MTX 7.5 to 25 mg once weekly

DRUG

placebo adalimumab, placebo MTX

placebo injections once every other week after 2 injections at Baseline (adalimumab) placebo capsules once weekly (MTX)

Trial Locations (1)

Global Medical Information-Abbott, Abbott Park